BDSX 8-K 2026-11-05

BIODESIX INC (BDSX) 8-K dated 2026-11-05 — accession 0001193125-26-449738.

BIODESIX INC (BDSX) is a diagnostics & research company listed on NASDAQ.

BIODESIX INC filed a 8-K on 2026-11-05. Accession 0001193125-26-449738.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BDSX revenue for 2025-12-31 was $88.5M. Net income was -$35.3M. Revenue was up 24.1% from 2024-12-31 to 2025-12-31. BDSX currently screens at market cap $157.6M.

Not investment advice. The BDSX SEC hub lists recent forms. The stock page is the research view.